Ligand validation:6GA9

L2P: 2,3-DI-PHYTANYL-GLYCEROL

L2P is a Ligand Of Interest in 6GA9 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6GA9_L2P_A_302	37%	61%	0.122	0.898	0.64	0.86	-	-	2	0	54%	0.5435
6GA9_L2P_A_311	21%	59%	0.21	0.819	0.62	0.94	-	4	5	0	100%	1
6GA9_L2P_A_310	12%	60%	0.199	0.826	0.54	0.98	-	-	0	0	48%	0.4783
6GA3_L2P_A_311	55%	60%	0.157	0.926	0.65	0.87	-	2	0	0	100%	1
7XJE_L2P_A_303	51%	40%	0.13	0.905	0.64	1.69	-	7	2	1	87%	0.8696
6GAE_L2P_A_302	42%	61%	0.11	0.908	0.64	0.86	-	-	2	0	54%	0.5435
6GAA_L2P_A_302	41%	61%	0.113	0.909	0.64	0.86	-	-	3	0	54%	0.5435
6GAB_L2P_A_302	41%	61%	0.115	0.911	0.64	0.86	-	-	2	0	54%	0.5435
6GA5_L2P_A_302	40%	61%	0.115	0.908	0.64	0.86	-	-	1	0	54%	0.5435

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.